Taaffe Dennis R, Newton Robert U, Chambers Suzanne K, Nelson Christian J, Spry Nigel, Luo Hao, Schumacher Oliver, Joseph David, Gardiner Robert A, Hayne Dickon, Galvão Daniel A
Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Eur Urol Oncol. 2025 Apr;8(2):387-393. doi: 10.1016/j.euo.2024.09.012. Epub 2024 Oct 5.
An array of treatment-related toxicities result from androgen deprivation therapy (ADT) in patients with prostate cancer (PCa), compromising function and health-related quality of life (HRQoL). Exercise has been demonstrated to counter a number of these adverse effects including decreased HRQoL; however, when exercise should be initiated is less clear. This study aims to examine whether commencing exercise when ADT is initiated rather than later during treatment is more effective in countering adverse effects on HRQoL.
Men with PCa (48-84 yr) initiating ADT were randomised to immediate exercise (IMEX; n = 54) or delayed exercise (DEL; n = 48) for 12 mo. IMEX consisted of 6 mo of supervised resistance/aerobic/impact exercise commenced at the initiation of ADT with 6 mo of follow-up. DEL consisted of 6 mo of usual care followed by 6 mo of the same exercise programme. HRQoL was assessed using the Short Form-36 at baseline and 6 and 12 mo. Intention to treat was utilised for the analyses that included group × time repeated-measures analysis of variance using log transformed data.
There were a significant group × time interaction for the physical functioning domain (p = 0.045) and physical component summary score (p = 0.005), and a significant time effect for bodily pain (p < 0.001) and vitality domains (p < 0.001), with HRQoL maintained in IMEX and declining in DEL at 6 mo. Exercise in DEL reversed declines in vitality and in the physical component summary score, with no differences at 12 mo compared with baseline. Limitations include treatment alterations during the intervention.
Concurrently initiating exercise and ADT in patients with PCa preserves HRQoL, whereas exercise initiated while on established ADT regimens reverses declines in some HRQoL domains.
To avoid initial treatment-related adverse effects on health-related quality of life, exercise medicine should be initiated at the start of treatment.
前列腺癌(PCa)患者接受雄激素剥夺治疗(ADT)会产生一系列与治疗相关的毒性反应,损害功能和健康相关生活质量(HRQoL)。运动已被证明可对抗其中一些不良反应,包括HRQoL下降;然而,运动应何时开始尚不清楚。本研究旨在探讨在开始ADT时而非治疗后期开始运动,在对抗对HRQoL的不良反应方面是否更有效。
开始ADT的PCa男性患者(48 - 84岁)被随机分为立即运动组(IMEX;n = 54)或延迟运动组(DEL;n = 48),为期12个月。IMEX包括在开始ADT时开始的6个月有监督的抗阻/有氧/冲击运动及6个月的随访。DEL包括6个月的常规护理,随后是相同的运动计划6个月。在基线、6个月和12个月时使用简明健康调查问卷(Short Form - 36)评估HRQoL。分析采用意向性分析,包括使用对数转换数据的组×时间重复测量方差分析。
在身体功能领域(p = 0.045)和身体成分总结得分(p = 0.005)存在显著的组×时间交互作用,在身体疼痛领域(p < 0.001)和活力领域(p < 0.001)存在显著的时间效应,在6个月时IMEX组的HRQoL得以维持而DEL组下降。DEL组的运动逆转了活力和身体成分总结得分的下降,与基线相比在12个月时无差异。局限性包括干预期间的治疗改变。
PCa患者同时开始运动和ADT可维持HRQoL,而在既定ADT方案期间开始的运动可逆转某些HRQoL领域的下降。
为避免初始治疗相关的对健康相关生活质量的不良影响,运动医学应在治疗开始时启动。